openPR Logo
Press release

Gastrointestinal Stromal Tumor Market SWOT Analysis, Latest Innovations, Emerging Trends, Industry Size, Growth Prospects and Forecast 2029

05-16-2023 09:00 PM CET | Health & Medicine

Press release from: DBMR

Gastrointestinal Stromal Tumor Market

Gastrointestinal Stromal Tumor Market

Being a proficient and comprehensive, Gastrointestinal Stromal Tumor Market survey report puts a light on primary and secondary drivers, market share, leading segments, possible sales volume, and geographical analysis. This market research report contains thorough analysis of the market structure along with forecast of the various segments and sub-segments of the market. A numerous markets, marketing strategies, trends, future products and rising opportunities are taken into consideration while studying market and preparing this report. The chief areas covered in the wide ranging Gastrointestinal Stromal Tumor market report include market definition, market segmentation, competitive analysis and research methodology.

The global gastric cancer market is expected to witness significant growth during the forecast period. Gastrointestinal stromal tumors (GISTs) are one of the world's most common mesenchymal tumors. As per the World Health Organization records, the projected occurrence rate of gastrointestinal stromal tumors is 14.5 per million, and is widespread in 129 people from a sample of a million, in the United States. Over the past few decades, the understanding, awareness and treatment of GISTs has observed tremendous progress. COVID-19 also had a major impact on the market growth.

Data Bridge Market Research analyses a growth rate in the global gastrointestinal stromal tumor market in the forecast period 2029. The expected CAGR of global gastrointestinal stromal tumor market is around 6.60% in the mentioned forecast period. The market was valued at USD 1.07 billion in 2021, and it would grow upto USD 1.78 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Opportunities

Increase in Hospital Demand
The treatment of gastrointestinal stromal tumor is primarily performed in hospitals due to the strict guidelines. Prolonged post-treatment hospitalization period and increased morbidity of gastrointestinal stromal tumor continue to boost the presence of hospitals. By the end of 2026, more than US$ 480 Mn worth of revenues will be produced from treating GISTs in hospitals worldwide. During the forecast period, specialized cancer treatment centers will also emerge as a main end-user in the global gastrointestinal stromal tumor market.

Rising Healthcare Awareness
Health awareness amongst the population are rising which results in the prediction of drugs boost the market growth. The innovative launches in medications for treating gastric cancer are expected to prompt the market simultaneously. Different researchers are investing in launching the drugs that benefit the market. This creates more opportunity in the market.

Increasing Demand for Chemotherapy
Treatment of gastrointestinal stromal tumor is a multidisciplinary approach, involving the contribution of medical oncologists, surgeons, radiologist, as well as pathologists. So far, radiotherapy's role in treating gastrointestinal stromal tumor remains determinedly unestablished. Most patients suffering from this tumor choose symptomatic treatments such as conventional chemotherapy as surgery is not possible in most cases. Thus, this factor create much opportunity for the market growth.

Segmentation:

The global gastrointestinal stromal tumor market is segmented on the basis of treatment type, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment Type

Chemotherapy
Targeted Therapy
Others
Route of Administration

Oral
Parenteral
Others
End-Users

Hospitals
Homecare
Speciality Centres
Others
Distribution Channel

Hospital Pharmacy
Online Pharmacy
Retail Pharmacy

Key Market Players:

Mylan N.V. (U.S.)
Teva Pharmaceutical Industries Ltd.(Israel)
Sanofi (France)
Pfizer Inc. (U.S.)
GSK plc (U.K.)
Novartis AG (Switzerland)
Bayer AG (Germany)
Eli Lilly and Company (U.S.)
Merck & Co., Inc. (U.S.)
Johnson & Johnson Private Limited (U.S.)
Cipla Inc. (U.S.)
Abbott (U.S.)
AbbVie Inc. (U.S.)
Sun Pharmaceutical Industries Ltd. (India)
Aurobindo Pharma (India)
Lupin (India)
Hikma Pharmaceuticals PLC (U.K.)
Blueprint Medicines Corporation (U.S.)
NATCO Pharma Limited (India)
Attractions of The Gastrointestinal Stromal Tumor Market Report: -

Latest market dynamics, development trends and growth opportunities are presented along with industry barriers, developmental threats and risk factors
The forecast Gastrointestinal Stromal Tumor Market data will help in the feasibility analysis, market size estimation and development
The report serves as a complete guide which micro monitors all vital Gastrointestinal Stromal Tumor Market
A concise market view will provide ease of understanding.
Nut Oil Market Competitive market view will help the players in making a right move
Key Questions Answered

What impact does COVID-19 have made on Global Gastrointestinal Stromal Tumor Market Growth & Sizing?
Who are the Leading key players and what are their Key Business plans in the Global Gastrointestinal Stromal Tumor Market?
What are the key concerns of the five forces analysis of the Global Gastrointestinal Stromal Tumor Market?
What are different prospects and threats faced by the dealers in the Global Gastrointestinal Stromal Tumor Market?
What are the strengths and weaknesses of the key vendors?

Browse More Info @ https://www.databridgemarketresearch.com/reports/global-gastrointestinal-stromal-tumor-market

More Reports:
https://sagark18dbmr.blogspot.com/2023/05/dental-software-market-growth-segments.html
https://sagark18dbmr.blogspot.com/2023/05/surgical-tumor-ablation-market-analysis.html
https://sagark18dbmr.blogspot.com/2023/05/kidney-and-pancreas-transplant-market.html

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email - corporatesales@databridgemarketresearch.com

About Us:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Data Bridge Market Research provides appropriate solutions to complex business challenges and initiates an effortless decision-making process.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gastrointestinal Stromal Tumor Market SWOT Analysis, Latest Innovations, Emerging Trends, Industry Size, Growth Prospects and Forecast 2029 here

News-ID: 3056125 • Views:

More Releases from DBMR

Feed Pigments Market - Industry Trends and Forecast
Global Feed Pigments Market, By Type (Carotenoids, Curcumin, Caramel, Spirulina and Others), Carotenoids Source (Natural and Synthetic), Livestock (Swine, Poultry, Ruminants, Aquatic Animals and Others) - Industry Trends and Forecast to 2029. Feed Pigments Market Analysis and Size Feed pigments are used to enhance the colour of products such as eggs, meat, and milk. The key drivers for this market are rising meat production demand, rising disposable incomes, a shift toward pellet
Automatic Brewing Equipment Market - Industry Trends and Forecast
Global Automatic Brewing Equipment Market, By Brewery Type (Macrobrewery, Craft Brewery), Equipment Type (Macrobrewery Equipment, Craft Brewery Equipment), Material Type (Brass, CopperAluminumStainless steel, Mild steel) - Industry Trends and Forecast to 2029. Automatic Brewing Equipment Market Analysis and Size Beers provide antioxidants and are a low-calorie alternative to other drinks. Along with being appropriately rich in vitamin B, vitamin B3, and vitamin B6, it also gives our bodies with vital fibre content.
Digestive Health Food and Drinks Market - Industry Trends and Forecast
Data Bridge Market Research analyses that the global digestive health food and drinks market to account USD 63.43 billion by 2029 growing at a CAGR of 7.85% in the forecast period of 2022-2029. Digestive health drinks are products that help to counteract the effects of an overburdened digestive tract. Drinks, when consumed properly, can aid in the prevention of a variety of small and large intestine health problems. There are
Activin A Market Size, Share, Growth, Trends and Forecast
Activin A market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 12.50% in the above mentioned forecast period. Activin A is a member of the TGF-beta super family and shows structural similarities with TGF-beta 1. Activins are the disulphide linked dimeric proteins that causes stimulation of pituitary follicle stimulating hormone

All 5 Releases


More Releases for Gastrointestinal

Gastrointestinal (GI) Stents Market is Driven by Rising Prevalence of Gastroint …
The Gastrointestinal (GI) Stents Market research report provides an in depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. Growth rate, market share captured, and valuation estimates for each region, segment, and company are documented as well. View Report - https://www.theinsightpartners.com/reports/gastrointestinal-gi-stents-market/ Gastrointestinal stents are used as an effective alternate to perform
Gastrointestinal Devices Market Report 2018: Segmentation by Type (Gastrointesti …
Global Gastrointestinal Devices market research report provides company profile for Coloplast, Given Imaging, CONMED, Covidien, Ethicon, Olympus, Boston Scientific and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation
Gastrointestinal Stents Market: Rising Incidences of Gastrointestinal Diseases t …
The world market for gastrointestinal stents has been assessed by a recent publication by Transparency Market Research. The market has been characterized with the presence of a few market players and is considered to be highly consolidated. The world gastrointestinal stents market is dominated by Boston Scientific Corporation and it held around 66.2% share of the total market in the year 2016. The same market, however, features fragmentation owing to
Gastrointestinal Stents Market: Rising Incidences of Gastrointestinal Diseases t …
The world market for gastrointestinal stents has been assessed by a recent publication by Transparency Market Research. The market has been characterized with the presence of a few market players and is considered to be highly consolidated. The world gastrointestinal stents market is dominated by Boston Scientific Corporation and it held around 66.2% share of the total market in the year 2016. The same market, however, features fragmentation owing to
Gastrointestinal Drugs Market - Upcoming Trends
The global gastrointestinal drugs market is consolidated with the top three players accounting for a whopping 61% of the market collectively in 2016. These three players are: Valeant Pharmaceuticals Inc., Janssen Biotech Inc., and Takeda Pharmaceutical. While the market is moderately competitive at present, future holds much competitiveness among players and thus, the degree of competition is expected to be increase in the forecast period, states a report by Transparency
Global Gastrointestinal Industry Report 2016
Global Gastrointestinal Industry 2016 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2016-2020. The analysts of the global Gastrointestinal market report have taken on the challenge of procuring insightful data from reliable resources and precisely segregating critical market dynamics, given the voluminous amount of information available. Established and novice players in the Gastrointestinal market can secure their position on the cutting edge